Suffering from a rare and aggressive form of cancer, Ian Brooks was given only weeks to live, Daily Mail reports.

With around 70 tumours throughout his body, doctors admitted they had almost run out of treatment options, Daily Mail reports.

But the second scan taken after only a few weeks on the US drug Brentuximab Vedotin shows an amazing improvement. Mr Brooks, 47, is now in ‘complete remission’.

The clinical trial at The Christie Hospital in Manchester has been so successful that the drug has been made routinely available to other sufferers. Now patients with the same rare form of Non-Hodgkin’s Lymphoma can get the drug through the Cancer Drugs Fund.

Mr Brooks had a rare form of Non-Hodgkin’s called Anaplastic Large Cell Lymphoma. Brentuximab Vedotin targets this strain of the disease and can put patients into ‘complete remission’ when there would otherwise be few treatment options available.

His doctor, Dr Adam Gibb, a clinical research fellow in lymphoma at The Christie, said: ‘The drug can be administered rapidly and has few side effects.'

«Лекарство быстро усваивается организмом и имеет мало побочных эффектов», - сказал лечащий врач Брукса доктор Адам Гибб из больницы Кристи.